$0.00360
-0.00022-5.88%
At close: -
$0.00310
-0.00050-13.89%
After Hours: Apr 2, 8:07 AM EDT
Comments
Loading...
AXIM Biotechnologies Analyst Ratings and Price Targets | OTC:AXIM | Benzinga
AXIM Biotechnologies Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for AXIM Biotechnologies Corp from these most-recent analyst ratings.
Analyst Ratings for AXIM Biotechnologies
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for AXIM Biotechnologies (AXIM) stock?
There is no price target for AXIM Biotechnologies
What is the most recent analyst rating for AXIM Biotechnologies (AXIM)?
There is no analyst for AXIM Biotechnologies
When was the last upgrade for AXIM Biotechnologies (AXIM)?
There is no last upgrade for AXIM Biotechnologies
When was the last downgrade for AXIM Biotechnologies (AXIM)?
There is no last downgrade for AXIM Biotechnologies.
When is the next analyst rating going to be posted or updated for AXIM Biotechnologies (AXIM)?
There is no next analyst rating for AXIM Biotechnologies.
Is the Analyst Rating AXIM Biotechnologies (AXIM) correct?
There is no next analyst rating for AXIM Biotechnologies.
Browse analyst ratings and price targets on all stocks.